MLH1 and cancer: Moreover, all malignant tumors with MSI are characterized by a similar phenotype, regardless of which of the mismatch genes that are mutated - this includes MSI “high” cancers due to MLH1 inactivation; whether it is by germline mutations or epigenetic silencing [20].